MF
Insider
Marshall Fordyce
PRESIDENT AND CEOMarshall Fordyce (PRESIDENT AND CEO) filed 10 Form 4 reports in the trailing twelve months (0 purchases, 10 sales, 3 filed past the two-business-day deadline), most often in Vera Therapeutics, Inc. (VERA). The largest single filing was $1.8M of VERA (43,050 sh across 2 lots, as filed), executed Jul 7.
Add to watchlistReturn, ttmiAverage return per filing, trailing twelve months
–
no purchases on file
Delay-adjustediThe same average, entered at disclosure dates
–
returns measure stock purchases only
Filings, ttm
10
0 buys · 10 sells · 3 late
Median delay
–
execution → disclosure
Volume, ttmiDollar value disclosed in the trailing twelve months
$9.4M
shares × price, as filed
Last traded
Sep 15
Filed Sep 17
Median ADV $64.6M across their filed names
Open performance→Volume by month
Buys $0
Sells $14.9M
Shares × price, as filed · by filing month · past 24 months
Sectors filed on
Healthcare
10 filings
Sector per market data · by filing · past 12 months
Most traded names
VERA
Vera Therapeutics, Inc.
VERA · 0 buys · 19 sells
19 filings
Recent filings
VERASALE
Vera Therapeutics, Inc.
View filing →
$664K16,465 sh across 2 lots
Exec Oct 23 2024
Filed Oct 25 2024 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. View filing → $598K
15,625 sh across 2 lots
Exec Oct 9 2024
Filed Oct 11 2024 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. View filing → $719K
15,625 sh across 3 lots
Exec Sep 25 2024
Filed Sep 27 2024 · 5:30 PM ET VERASALE Vera Therapeutics, Inc. View filing → $586K
15,625 sh across 2 lots
Exec Sep 11 2024
Filed Sep 13 2024 · 5:30 PM ET